Evangelos Terpos

53.8k citations
869 papers · 23.7k indexed · 9 hit papers · h-index 77
Topics
Multiple Myeloma Research and Treatments (497 papers)Bone health and treatments (186 papers)Protein Degradation and Inhibitors (134 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Evangelos Terpos

814 papers receiving 23.2k citations

Hit Papers

Hematological findings ...2005202620122019202020052017202120182505007501000

Peers

Evangelos Terpos
Comparison fields: 5 of 160
  • Oncology 11.7k
  • Hematology 11.4k
  • Molecular Biology 8.6k
  • Genetics 3.6k
  • Infectious Diseases 2.8k
Replace Efstathios Kastritis with:
Efstathios Kastritis Greece
Ching‐Hon Pui United States
Yoshiya Tanaka Japan
Martin S. Tallman United States
Elihu H. Estey United States
Stanley Cohen United States
Bart Barlogie United States
Josef S Smolen Austria
Hillard M. Lazarus United States
Guido Tricot United States
Evangelos Terpos relative to Efstathios Kastritis Greece Efstathios Kastritis's profile →
Citations per field
00.5×1.5×2.4×
Efstathios Kastritis · 1×
Citations per year

Countries citing papers authored by Evangelos Terpos

Since Specialization
Citations

This map shows the geographic impact of Evangelos Terpos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Terpos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Terpos more than expected).

Fields of papers citing papers by Evangelos Terpos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Terpos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Terpos. The network helps show where Evangelos Terpos may publish in the future.

Co-authorship network of co-authors of Evangelos Terpos

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Terpos. A scholar is included among the top collaborators of Evangelos Terpos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Terpos. Evangelos Terpos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 7
5 2
6 2
7 7
8 2
9 1
10 9
11 14
12 21
13 5
14 12
15 23
16
Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass.
0
17 31
18 142
19 2
20 307

About Evangelos Terpos

Evangelos Terpos is a scholar working on Hematology, Genetics and Oncology, having authored 869 papers that have together received 23.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (497 papers), Bone health and treatments (186 papers) and Protein Degradation and Inhibitors (134 papers). The work is most often cited by research in Hematology (11.4k citations), Oncology (11.7k citations) and Genetics (3.6k citations). Evangelos Terpos has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Meletios Α. Dimopoulos, Efstathios Kastritis, Ioannis Ntanasis‐Stathopoulos, Maria Gavriatopoulou, Ersi Voskaridou, Amin Rahemtulla, Μαρία Ρούσσου, Despina Fotiou, Θεοδώρα Ψαλτοπούλου and Lia A. Moulopoulos. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026